Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer

Hepatology

Volumn 26, Issue 4, 1997, Pages 998-1005

  Louha, Malek ^a   Poussin, Karine ^a   Ganne, Nathalie ^b   Zylberberg, Herve ^c   Nalpas, Bertrand ^a   Nicolet, Jerome ^d   Capron, Frederique ^d   Soubrane, Olivier ^e   Vons, Corinne ^d   Pol, Stanislas ^c   Beaugrand, Michel ^b   Berthelot, Pierre ^c   Franco, Dominique ^d   Trinchet, Jean Claude ^b   Bréchot, Christian ^a,c   Paterlini, Patrizia ^a  

^a INSERM   (France)

^b HÔPITAL JEAN VERDIER   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d HÔPITAL ANTOINE BÉCLÈRE   (France)

^e Hôpital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; MESSENGER RNA;

ARTICLE; ARTIFICIAL EMBOLISM; BLOOD; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; GENETIC MARKER; HUMAN; HUMAN CELL; HUMAN TISSUE; IATROGENIC DISEASE; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; TUMOR CELL; TUMOR EMBOLISM; TUMOR VOLUME;

EID: 12644291946     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260430     Document Type: Article

References (53)

1. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-699.
2. Trinchet J-C, Rached A, Beaugrand M, Mathieu D, Chevret S, Chastang C. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995; 332:1256-1261.
3. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991;15:270-285.
4. Zhou X-D, Tang Z-Y, Yu Y-Q, Yang B-H, Lin Z-Y, Lu J-Z, Ma Z-C. Long-term results of surgery for small primary liver cancer in 514 adults. J Cancer Res Clin Oncol 1996;122:59-62.
5. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993;218:145-151.
6. Marcos-Alvarez A, Jenkins R, Washburn W, Lewis D, Stuart K, Gordon F, Kane R, et al. Multimodality treatment of hepatocelluar carcinoma in Hepatobiliary Speciality Center. Arch Surg 1996;131:292-298.
7. Colombo M. Hepatocellular carcinoma. J Hepatol 1992;15:225-236.
8. Kew MC. Role of cirrhosis in hepatocarcinogenesis. In: Bannasch P, Keppler D, Weber G, eds. Liver Cell Carcinoma. Dordrecht, The Netherlands: Kluwer Academic, 1989:37-45.
9. Zaman S, Johnson P, Williams R. Silent cirrhosis in patients with hepatocellular carcinoma. Cancer 1990;65:1607-1610.
10. Colombo M, De Franchis K, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, Donato MF, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675-680.
11. Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K, Tsuneyoshi M. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995;108:768-775.
12. Dusheiko G, Hobbs K, Dick R, Burrough S. Treatment of small hepatocellular carcinomas. Lancet 1992;340:285-288.
13. Gozzetti G, Belli L, Capussotti L Di Carlo, V, Gennari L, Maffei Faccioli A, Mazziotti A, Spina P. Liver resection for hepatocellular carcinoma in cirrhotic patients. Ital J Gastroenterol 1992;24:105-110.
14. Tsuzuki T, Sugioka A, Ueda M, Iida S, Kanai T, Yoshii H, Nakayasu K. Hepatic resection for hepatocellular carcinoma. Surgery 1990;107:511-520.
15. Franco D, Capussotti L, Smadja C, Bouzari H, Meakins J, Kemeny F, Grange D, et al. Resection of hepatocellular carcinoma. Results in 72 European patients with cirrhosis. Gastroenterology 1990;98:733-738.
16. Belghiti J, Panis O, Benhamou P, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma. Ann Surg 1991;214:114-117.
17. Vilana R, Bruix J, Bru C, Ayuso C, Solé M, Rodés J. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. HEPATOLOGY 1992;16:353-357.
18. Livraghi T, Buscarini L, Cottone M, Mazziotti A, Morabito A, Torzilli G. No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. J Hepatol 1995;22:522-526.
19. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56:918-928.
20. Yuki K, Hirohashi S, Sakamoto M, Kanai T, Shimosato Y. Growth and spread of hepatocellular cacinoma. Cancer 1990;66:2174-2179.
21. Mazzaferro V, Rondinara G, Rossi G, Regalia E, De Carlis L, Caccamo L, Doci R, et al. Milan Multicenter experience in liver transplantation for hepatocellular carcinoma. Transplant Proc 1994;26:3557-3560.
22. Selby R, Kadry Z, Carr B, Tzakis A, Madariaga J, Iwatsuki S. Liver transplantation for hepatocellular carcinoma. World J Surg 1995;19: 53-58.
23. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991;110:726-735.
24. Calne S, Yamanoi A, Oura S, Kawamura M. Liver transplantation for hepatocarcinoma. Surg Today 1993;23:1-3.
25. Iwatsuki S, Starzl T, Sheahan D, Yokoyama I, Demetris A, Todo S, Tzakis A, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991;214:221-229.
26. Tan K, Rela M, Ryder S, Rizzi P, Karani J, Portmann B, Heaton N, et al. Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis. Br J Surg 1995:253-256.
27. Schwartz M. Primary hepatocellular carcinoma: transplant versus resection. Semin Liv Disease 1994;14:135-139.
28. Hillaire S, Barbu V, Boucher E, Moukhtar M, Poupon R. Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma. Gastroenterology 1994;106:239-242.
29. Matsumura M, Niwa Y, Kato N, Komatsu Y, Shiina S, Kawabe T, Kawase T, et al. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. HEPATOLOGY 1994; 20:1418-1425.
30. Kar S and Carr B. Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma. HEPATOLOGY 1995;21: 403-407.
31. Komeda T, Fukuda Y, Sando T, Kita R, Furukawa M, Nishida N, Amenomori M, et al. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 1995;75:2214-2219.
32. Kaplan E and Meier P. Nonparametric estimation from incomplete ob-servations. J Am Stat Assoc 1958:53:
33. Peto R and Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc 1972;135:185-206.
34. Paterlini P, Flejou J-F, De Mitri M, Pisi E, Franco D, Berchot C. Structure and expression of the cyclin A gene in human primary liver cancer. Correlation with flow cytometric parameters. J Hepatol 1995;23:47-52.
35. Kakajima-Iijima S, Hamada H, Reddy P, Kakunaga T. Molecular structure of the human cytoplasmic β-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci U S A 1985;82:6133-6137.
36. Minghetti P, Ruffner D, Kuang W-J, Dennison O, Hawkins J Beattie, WG, Dugaiczyk A. Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11-22 of chromosome 4. J Biol Chem 1986;261:6747-6757.
37. Morinaga T, Sakai M, Wegmann T, Tamaoki T. Primary structures of human α-fetoprotein and its mRNA. Proc Natl Acad Sci USA 1983; 80:4604-4608.
38. de Pagter-Holthuizen P, Jansen M, van der Kammen R, van Schaik F, Sussenbach J. Differential expression of the human insulin-like growth factor II gene. Characterization of the IGF-II mRNAs and an mRNA encoding a putative IGF-II associated protein. Biochem Biophys Acta 1988;950:282-295.
39. Chelly J, Concordet J, Kaplan J-C, Kahn A. Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci U S A 1989;86:2617-2621.
40. Jaakkola S, Vornanen T, Leinonen J, Rannikko S, Stenman U. Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate-specific antigen. Clin Chem 1995;412:182-186.
41. Datta Y, Adams P, Drobyski W, Ethier S, Terry V, Roth M. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 1994;12:475-482.
42. Chomczynski P and Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
43. Féray C, Samuel D, Thiers V, Gigou M, Pichon F, Bismuth A, Reynes AM, et al. Reinfection of liver graft by hepatitis C virus (HCV) after liver transplantation. J Clin Invest 1992;89:1361-1365.
44. Paterlini P, Poussin K, Kew M, Franco D and Bérchot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. HEPATOLOGY 1995;21:313-321.
45. Camper S, Godbout R, Tilghman S. The developmental regulation of albumin and α-fetoprotein gene expression. Prog Nucleic Acid Res Mol Biol 1989;36:131-143.
46. Cariani E, Lasserre C, Kemeny F, Franco D, Bérchot C. Expression of insulin-like growth factor II, alpha-fetoprotein and hepatitis B virus transcripts in human primary liver cancer. HEPATOLOGY 1991;13:644-649.
47. Niwa Y, Matsumura M, Shiratori Y, Imamura M, Kato N, Shiina S, Okudaira T, et al. Quantitation of α-fetoprotein and albumin messenger RNAs in human hepatocellular carcinoma. HEPATOLOGY 1996;23:1384-1392.
48. Heyward W, Bender T, Lanier A, Francis D, McMahon B, Maynard J. Serological markers of hepatitis B virus and alphafetoprotein levels preceding primary hepatocellular carcinoma in Alaskan Eskimos. Lancet 1982;2:889-891.
49. Carr B and Kar S. An assay for hepatoma micrometastasis: albumin gene expression in peripheral blood from patients with advanced hepatocellular carcinoma [Abstract]. HEPATOLOGY 1991;14:242A.
50. Chou H-C, Sheu J-C, Huang G-T, Wang J-T, Chen D-S. Albumin messager RNA is not specific for circulating hepatoma cells. Gastroenterology 1994;107:630-631.
51. Müller C, Petermann D, Pfeffel F, Oesterreicher C, Függer R. Lack of specificity of albumin-mRNApositive cells as a marker of circulating hepatoma cells. HEPATOLOGY 1997;25:896-899.
52. Paterlini P, Lallemand-Le Coeur S, Lallemand M, M'Pelé P, Dazza M, Terre S, Moncany M, et al. Polymerase chain reaction for studies of mother to child transmission of HIV1 in Africa. J Med Virol 1990;30: 53-57.
53. De Franchi R, Cross N, Foulkes N and Cox T. A potent inhibitor of Taq polymerase copurifies with human genomic DNA. Nucleic Acids Res 1988;16:10355.